Date   Title

March 15, 2021   COVID-19 Antibody Tests For Variants Now Available Worldwide

December 1, 2020   COVID-19 Antibody Tests Used In Vaccine Clinical Trials Now Available Worldwide

February 26, 2019   CORE Advancing Meso Scale Discovery for Tear Film Biomarker Identification

January 29, 2018   Meso Scale Diagnostics Receives First FDA Clearance for IVD Assay

February 22, 2017   Meso Scale Discovery Launches New V-PLEX® Assays for Th17 Research

August 30, 2016   Meso Scale Discovery Launches α-Synuclein Assay for Parkinson’s Disease Research

June 8, 2015   Meso Scale Discovery Launches Its New Services for the Acceleration of Biomarker Research

February 18, 2015   Meso Scale Discovery Launches Its New U-PLEX Platform for Personalized Immunoassay Multiplexing  

May 23, 2014   MSD Biomarker Assays Selected for Resveratrol Study in Alzheimer’s Disease

May 21, 2014   Meso Scale Discovery Introduces Its New S-PLEX High-Sensitivity Biomarker Immunoassay Technology

March 5, 2014   BioAgilytix Becomes the First CRO to Validate Meso Scale Discovery’s V-PLEX Human Cytokine 30-Plex Assay

September 11, 2013   Meso Scale Discovery Launches V-PLEX Multiplex Biomarker Immunoassays

July 17, 2013   Meso Scale Discovery Launches New QuickPlex SQ 120 Multiplex Immunoassay Instrument

August 3, 2012   Meso Scale Diagnostics Announces ISO 9001:2008 and ISO 13485:2003 Certifications

March 28, 2012   Bristol-Myers Squibb and MESO SCALE DISCOVERY Enter Agreement to Develop Diagnostic Assays for Alzheimer's Disease

October 27, 2011   Biomed Realty Trust and MESO SCALE DIAGNOSTICS Announce 104,700 Square Foot Lease at 1701 Research Boulevard in Maryland

May 4, 2009   MESO SCALE DIAGNOSTICS' Point of Care Influenza Test Led to the First Identification of A(H1N1) Swine Flu Infection
Customer Service/Orders

Scientific/Technical Support

Instrument Support

Company Headquarters